Skip to search formSkip to main contentSkip to account menu

meningococcal polysaccharide vaccine (MPSV4)

Known as: Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combination, Meningococcal Polysaccharide Vaccine MPS-4, Meningococcal Polysaccharide Vaccine MPSV-4 
A polysaccharide vaccine used to prevent contraction of meningococcal meningitis.
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Meningococcal vaccine
Meningococcal vaccine componentPolysaccharide Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
This report summarizes and updates an earlier published statement issued by the Advisory Committee on Immunization Practices… 
Highly Cited
1997
Highly Cited
1997
Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose
Exogenous sialylation of gonococcal lipooligosaccharide causes resistance to serum bactericidal activity. The aim of this study… 
Highly Cited
1992
Highly Cited
1992
Helical epitope of the group B meningococcal alpha(2-8)-linked sialic acid polysaccharide.
The immunological properties of the group B meningococcal alpha(2-8)-linked sialic acid polysaccharide have been rationalized in… 
Highly Cited
1991
Highly Cited
1991
Rapid diagnosis of meningococcal meningitis by polymerase chain reaction
Review
1991
Review
1991
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.
Results from the serum bactericidal assay (BA) after immunization of human volunteers with the Norwegian serogroup B… 
Highly Cited
1987
Highly Cited
1987
Conformational differences between linear alpha (2----8)-linked homosialooligosaccharides and the epitope of the group B meningococcal polysaccharide.
The alpha-(2----8)-linked sialic acid oligosaccharides (NeuAc)n exhibit an unusual degree of heterogeneity in the conformation of… 
Highly Cited
1984
Highly Cited
1984
Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.
Highly Cited
1982
Highly Cited
1982
Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens
Although effective polysaccharide vaccines have been developed for meningococcal groups A, C, Y, and W135, the purified group B… 
Highly Cited
1975
Highly Cited
1975
Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
Serum Haemophilus influenzae Type b (HITB) anticapsular antibodies were induced in adult volunteers by feeding of either of two… 
Highly Cited
1971
Highly Cited
1971
Immunologic investigations of meningococcal disease. I. Group-specific Neisseria meningitidis antigens present in the serum of patients with fulminant meningococcemia.
Patients with fatal fulminant meningococcemia had readily detectable levels of soluble group-specific meningococcal antigen in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)